These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22136862)

  • 61. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
    Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
    Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
    [No Abstract]   [Full Text] [Related]  

  • 62. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
    Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
    [No Abstract]   [Full Text] [Related]  

  • 63. Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).
    Ceesay MM; Matutes E; Taylor GP; Fields P; Cavenagh J; Simpson S; Ho A; Devereux S; Mufti GJ; Pagliuca A
    Leuk Res; 2012 Jul; 36(7):857-61. PubMed ID: 22209076
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Subcutaneous panniculitislike T-cell lymphoma with hemophagocytosis: complete remission with BFM-90 protocol.
    Medhi K; Kumar R; Rishi A; Kumar L; Bakhshi S
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):558-61. PubMed ID: 18797207
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Case records of the Massachusetts General Hospital. Case 24-2013. A 53-year-old woman with erythroderma, pruritus, and lymphadenopathy.
    Carter JB; Barnes JA; Niell BL; Nardi V
    N Engl J Med; 2013 Aug; 369(6):559-69. PubMed ID: 23924007
    [No Abstract]   [Full Text] [Related]  

  • 66. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
    Kahata K; Hashino S; Takahata M; Fujisawa F; Kondo T; Kobayashi S; Fujita Y; Shimizu H; Imamura M; Asaka M
    Acta Haematol; 2008; 120(1):14-8. PubMed ID: 18716396
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
    Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observations.
    Rook AH; Prystowsky MB; Cassin M; Boufal M; Lessin SR
    Arch Dermatol; 1991 Oct; 127(10):1535-40. PubMed ID: 1929461
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Primary cutaneous diffuse large B-cell lymphoma, leg type, with features simulating POEMS syndrome.
    Nakayama S; Yokote T; Kobayashi K; Hirata Y; Akioka T; Miyoshi T; Oka S; Hiraoka N; Iwaki K; Takayama A; Takubo T; Tsuji M; Hanafusa T
    Eur J Haematol; 2010 Jan; 84(1):79-83. PubMed ID: 19558504
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnostic tools in Sezary syndrome.
    Möbs M; Knott M; Fritzen B; Pullmann S; Sterry W; Assaf C
    G Ital Dermatol Venereol; 2010 Jun; 145(3):385-91. PubMed ID: 20461046
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [New developments in Sézary syndrome].
    Caudron A; Marie-Cardine A; Bensussan A; Bagot M
    Ann Dermatol Venereol; 2012 Jan; 139(1):31-40. PubMed ID: 22225740
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cutaneous tumor cell load correlates with survival in patients with Sézary syndrome.
    Booken N; Nicolay JP; Weiss C; Klemke CD
    J Dtsch Dermatol Ges; 2013 Jan; 11(1):67-79. PubMed ID: 23167557
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sézary syndrome without erythroderma: A case report and review of published work.
    Kamijo H; Miyagaki T; Norimatsu Y; Shishido-Takahashi N; Kuzumi A; Asano Y; Sato S
    J Dermatol; 2019 Jan; 46(1):61-64. PubMed ID: 30379353
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Sézary syndrome treated with extracorporeal photopheresis: Report of one case].
    Molgó M; Jaque A; Vial V; Ocqueteau M; Pereira J; Chang M; González S
    Rev Med Chil; 2015 Nov; 143(11):1449-58. PubMed ID: 26757870
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Circulating cerebriform lymphoid cells (Sezary-type cells) in a B-cell malignant lymphoma.
    O'Briain DS; Lawlor E; Sarsfield P; Cooney C; Blaney CH; Sullivan FJ
    Cancer; 1988 Apr; 61(8):1587-93. PubMed ID: 2450633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Leonine facies: A unique presentation of T-prolymphocytic leukemia.
    Hasan F; Parashar Y; Rao RN; Kashyap R
    Indian J Pathol Microbiol; 2021; 64(4):817-819. PubMed ID: 34673613
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome.
    Jawed SI; Busam K; Wang X; Horwitz S; Querfeld C
    JAMA Dermatol; 2014 Sep; 150(9):1021-3. PubMed ID: 25029560
    [No Abstract]   [Full Text] [Related]  

  • 78. An unusual Sézary syndrome with concomitant pulmonary localization: aggressiveness of folliculotropic form.
    Brugière C; Stefan A; Salaun V; Comoz F; Campbell K; Chantepie S; Verneuil L
    Int J Dermatol; 2016 Jan; 55(1):81-4. PubMed ID: 24697708
    [No Abstract]   [Full Text] [Related]  

  • 79. [Atypical Sézary syndrome in a young subject].
    Jabran-Maanaoui S; Chauvet P; Gillard M; Carpentier B; Pascal L; Quinchon JF; Modiano P
    Ann Dermatol Venereol; 2020 May; 147(5):355-360. PubMed ID: 31806381
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cutaneous T-cell lymphoma's confounding nature.
    Schmidt C
    J Natl Cancer Inst; 2012 Jun; 104(11):806-8. PubMed ID: 22673589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.